Cite

    Mauldin, I. et al. (n.d.). Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine. Journal for immunotherapy of cancer. p. . [Online].